Freedom of Information request on how suspected reactions reported in association with available COVID-19 vaccines are published (FOI 21/474)
Published 28 June 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-24-may-2021/freedom-of-information-request-on-how-suspected-reactions-reported-in-association-with-available-covid-19-vaccines-are-published-foi-21474
24th May 2021 FOI 21/474
Dear
Thank you for your email. We intend to publish all suspected reactions reported in association with available COVID-19 vaccines in an interactive format as iDAPs, along with our ADR summary that is published each week. The use of iDAPs will enable users to view the data by categories of their choice such as age, sex and seriousness of reports. Users will also be able to download the data tables in CSV format. We would be happy to provide you with a link to this when it is published.
Kind regards,
FOI Team Vigilance and Risk Management of Medicines Division Medicines and Healthcare Products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU